Do not take AUBAGIO if you have severe liver problems, are pregnant or of childbearing potential and not using effective birth control, have had an allergic reaction to AUBAGIO or leflunomide, or are taking a medicine called leflunomide for rheumatoid arthritis.
VIEW IMPORTANT SAFETY INFORMATION

Lights, Camera, Take Action on MS

Television and movie star Madeleine Stowe has teamed up with Genzyme, the makers of once-daily oral AUBAGIO® (teriflunomide) to inspire people living with relapsing MS to take action to help manage their disease.

Madeleine Stowe, MS care partner to her late father, does not have MS and is not taking AUBAGIO.

Take Action on MS Webisode Series

Join us as Madeleine Stowe hosts a web series covering topics and questions asked directly by the MS Community.


Video Thumbnail Webisode 5: Asking the People Around Me for Help & Offering Help as a Care PartnerIn this episode, Madeleine Stowe and guests help you take action to let people know when you need them.
Preview Webisode Here

Video Thumbnail Webisode 1: Keeping Things in Perspective After Being DiagnosedIn this episode, Madeleine Stowe and her guests discuss how to keep your perspective after being diagnosed with relapsing MS.

Video Thumbnail Webisode 2: Caring for My Overall HealthJoin Madeleine Stowe and guests as they discuss exercise, fatigue and maintaining a positive attitude.
Preview Webisode Here

Video Thumbnail Webisode 3: Managing Feelings of Being OverwhelmedMadeleine Stowe and her guests share how you can keep from being overwhelmed while living with MS.
Preview Webisode Here

Video Thumbnail Webisode 4: Building Intimacy with a PartnerWhether you're in a long-term relationship or just started dating, Madeleine and her guests are shattering intimacy misconceptions.
Preview Webisode Here

Video Thumbnail Webisode 5: Asking the People Around Me for Help & Offering Help as a Care PartnerIn this episode, Madeleine Stowe and guests help you take action to let people know when you need them.
Preview Webisode Here

Click Here!Tap Here
to sign up to find out when new webisodes are live

Get information on AUBAGIO®, a pill you take once a day for the treatment of relapsing forms of MS.

Learn More

Learn more about a comprehensive program that provides 24/7 personal support to people living with MS – MS One to One®.

Learn More

INDICATION

AUBAGIO® (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS).

IMPORTANT SAFETY INFORMATION

DO NOT TAKE AUBAGIO IF YOU:

  • Have severe liver problems. AUBAGIO may cause serious liver problems, which can be life-threatening. Your risk may be higher if you take other medicines that affect your liver. Your healthcare provider should do blood tests to check your liver within 6 months before you start AUBAGIO and monthly for 6 months after starting AUBAGIO. Tell your healthcare provider right away if you develop any of these symptoms of liver problems: nausea, vomiting, stomach pain, loss of appetite, tiredness, yellowing of your skin or whites of your eyes, or dark urine.
  • Are pregnant. AUBAGIO may harm an unborn baby. You should have a pregnancy test before starting AUBAGIO. After stopping AUBAGIO, continue to use effective birth control until you have made sure your blood levels of AUBAGIO are lowered. If you become pregnant while taking AUBAGIO or within 2 years after stopping, tell your healthcare provider right away and enroll in the AUBAGIO Pregnancy Registry at 1-800-745-4447, option 2.
  • Are of childbearing potential and not using effective birth control.

    It is not known if AUBAGIO passes into breast milk. Your healthcare provider can help you decide if you should take AUBAGIO or breastfeed — you should not do both at the same time.

    If you are a man whose partner plans to become pregnant, you should stop taking AUBAGIO and talk with your healthcare provider about reducing the levels of AUBAGIO in your blood. If your partner does not plan to become pregnant, use effective birth control while taking AUBAGIO.

  • Have had an allergic reaction to AUBAGIO or a medicine called leflunomide.
  • Take a medicine called leflunomide for rheumatoid arthritis.

AUBAGIO may stay in your blood for up to 2 years after you stop taking it. Your healthcare provider can prescribe a medicine that can remove AUBAGIO from your blood quickly.

Before taking AUBAGIO, talk with your healthcare provider if you have: liver or kidney problems; a fever or infection, or if you are unable to fight infections; numbness or tingling in your hands or feet that is different from your MS symptoms; diabetes; serious skin problems when taking other medicines; breathing problems; or high blood pressure. Your healthcare provider will check your blood cell count and TB test before you start AUBAGIO. Talk with your healthcare provider if you take or are planning to take other medicines (especially medicines for treating cancer or controlling your immune system), vitamins or herbal supplements.

AUBAGIO may cause serious side effects, including: reduced white blood cell count — this may cause you to have more infections; numbness or tingling in your hands or feet that is different from your MS symptoms; serious skin problems; breathing problems (new or worsening); and high blood pressure. Patients with low white blood cell count should not receive certain vaccinations during AUBAGIO treatment and 6 months after.

Tell your doctor if you have any side effect that bothers you or does not go away.

The most common side effects when taking AUBAGIO include: headache; diarrhea; nausea; upset stomach; hair thinning or loss; and abnormal liver test results. These are not all the side effects of AUBAGIO. Tell your healthcare provider about any side effect that bothers you.

Consult your healthcare provider if you have questions about your health or any medications you may be taking, including AUBAGIO.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click here for full Prescribing Information, including boxed WARNING and Medication Guide.

IMPORTANT SAFETY INFORMATION
Do not take AUBAGIO if you have severe liver problems. AUBAGIO may cause serious liver problems, View More

Please fix errors below.

Sign up to receive campaign updates.
We'll let you know when new webisodes are live!

First name is required.
Last name is required.
Please enter a valid email address.
Please enter a valid Zip.

Optional: By checking this box, you agree that Sanofi Genzyme and its agents (such as third party business partners hired by Sanofi Genzyme) can send you information, offers and promotions regarding Sanofi Genzyme products, programs and services. Further, you authorize Sanofi Genzyme and its agents to ask you about your experience with and thoughts about products, services and programs that Sanofi Genzyme offers or sponsors. You understand that Sanofi Genzyme and its agents may need to share the information you provide above with one another in order to perform these activities. You also understand that Sanofi Genzyme does not permit your personal information to be used by any of its agents for their own separate marketing purposes. You may opt out of continued receipt of information, offers, promotions and other communications at any time by calling 1-855-676-6326 or by visiting http://unsubscribe.msgenzyme.com.

Other Use of Information: to de-identify the information about you and to use this de-identified information in performing clinical research, patient and community education, clinical protocol development, marketing studies or for other commercial purposes.

Thanks!

You have successfully been registered to
receive e-mail updates.
Thank you for your registration

Sign up to receive campaign updates.
We'll let you know when new webisodes are live!

First name is required.
Last name is required.
Please enter a valid email address.
Please enter a valid Zip.

Optional: By checking this box, you agree that Sanofi Genzyme and its agents (such as third party business partners hired by Sanofi Genzyme) can send you information, offers and promotions regarding Sanofi Genzyme products, programs and services. Further, you authorize Sanofi Genzyme and its agents to ask you about your experience with and thoughts about products, services and programs that Sanofi Genzyme offers or sponsors. You understand that Sanofi Genzyme and its agents may need to share the information you provide above with one another in order to perform these activities. You also understand that Sanofi Genzyme does not permit your personal information to be used by any of its agents for their own separate marketing purposes. You may opt out of continued receipt of information, offers, promotions and other communications at any time by calling 1-855-676-6326 or by visiting http://unsubscribe.msgenzyme.com.

Other Use of Information: to de-identify the information about you and to use this de-identified information in performing clinical research, patient and community education, clinical protocol development, marketing studies or for other commercial purposes.

Thanks!

You have successfully been registered to
receive e-mail updates.
Thank you for your registration

Share This Site

*All fields marked with an asterisk are required.

*Your Name:
Please provide your name.
*Recipient's Name:
Please provide recipient's name.
*Recipient's Email: Please enter a valid email address.
*Confirm Recipient's Email:
Please confirm the email of the recipient.
Email addresses do not match

Subject Line: I{{share.FromName}} thought this might be of interest to you.

CANCEL

Email sent!

Your email has been sent.

CLOSE

You Are About to Leave AUBAGIO.com

Genzyme Corporation does not review or control the content of non-Genzyme websites, and this hyperlink does not constitute an endorsement by Genzyme of the site's content. Genzyme's privacy procedures do not apply to the owners of a non-Genzyme website.


Continue CANCEL